The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Coding Corner Answers: A Drug Administration Quiz

Coding Corner Answers: A Drug Administration Quiz

November 19, 2018 • By From the College

  • Tweet
  • Email
Print-Friendly Version / Save PDF

Take the challenge.

You Might Also Like
  • Rheumatology Coding Corner Answers: 2017 End-of-Year Quiz
  • Coding Corner Questions: A Drug Administration Quiz
  • Coding Corner Answer: Rheumatology Coding & Practice Quiz
Explore This Issue
November 2018
Also By This Author
  • ALERT: 2010 ICD-9-CM/CPT Code Changes
one photo; Nata-Lia / shutterstock.com

one photo; Nata-Lia / shutterstock.com

  1. C—This claim cannot be coded without querying the infusion nurse and physician. There must be documentation of the patient’s weight to document the correct dosage of the medication to be given to the patient. Also the start time and the completion time of the infusion must be documented to know which drug administration code can be billed.
  2. C—There is no documentation of the medical necessity for an E/M visit. The drug denosumab, although it is a monoclonal antibody, does not meet the medical necessity for the higher chemotherapy injection code.
  3. D—Adalimumab is on the Self-Administrated Drug (SAD) list. CMS will reimburse for the office administration of a drug only if it is not a drug that a patient usually could administer himself. A list of the drugs on the SAD list can be found on your Medicare Administrative Carrier’s (MAC) website.
  4. B—The drug ibandronate sodium injection is administrated via an intravenous push. A nursing visit (99211) cannot be billed with any drug-administrated code, because the work of the nurse is built into the relative value unit (RVU) of the fee schedule.

For questions or additional information on coding and documentation guidelines, contact Melesia Tillman, CPC-I, CPC, CRHC, CHA, via email at [email protected] or call 404-633-3777 x820.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Filed Under: Billing/Coding, From the College Tagged With: adalimumab, Billing & Coding, denosumab, ibandronate sodium, infliximabIssue: November 2018

You Might Also Like:
  • Rheumatology Coding Corner Answers: 2017 End-of-Year Quiz
  • Coding Corner Questions: A Drug Administration Quiz
  • Coding Corner Answer: Rheumatology Coding & Practice Quiz
  • Rheumatology Coding Corner Year-End Quiz Answers

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2022 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)